Scott Harris
Corporate Officer/Principal chez TERNS PHARMACEUTICALS, INC.
Profil
Scott Harris is currently the Chief Development Officer at Terns Pharmaceuticals, Inc. He previously worked as the Chief Operating Officer at Cleave Therapeutics, Inc. Mr. Harris holds a graduate degree from San Diego State University and an undergraduate degree from the University of California San Diego.
Postes actifs de Scott Harris
| Sociétés | Poste | Début |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 28/05/2024 |
Anciens postes connus de Scott Harris
| Sociétés | Poste | Fin |
|---|---|---|
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Directeur des opérations | - |
Formation de Scott Harris
| University of California San Diego | Undergraduate Degree |
| San Diego State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
